Risk factors for atherosclerotic vascular diseases with special reference to the relationship between apolipoprotein E mutations and hyperlipidemia.
Yamamoto
A
A
Department of Etiology and Pathophysiology, National Cardiovascular Center Research Institute, Osaka, Japan.
Yamamura
T
T
Tajima
S
S
D001057:Apolipoproteins E / Q000235:genetics* / Q000378:metabolism; D001161:Arteriosclerosis / Q000209:etiology*; D008078:Cholesterol, LDL / Q000097:blood; D003327:Coronary Disease / Q000235:genetics; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications*; D008077:Lipoproteins, LDL / Q000378:metabolism; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D009154:Mutation; D010641:Phenotype; D011973:Receptors, LDL / Q000378:metabolism; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood
D001057:Apolipoproteins E; D008078:Cholesterol, LDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D011973:Receptors, LDL; D014280:Triglycerides; C030106:very low density lipoprotein triglyceride